Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$79.4 - $116.36 $1,508 - $2,210
-19 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$86.42 - $109.81 $1,641 - $2,086
19 New
19 $2,000
Q2 2021

Aug 12, 2021

SELL
$86.24 - $95.92 $695,353 - $773,402
-8,063 Closed
0 $0
Q1 2021

May 06, 2021

BUY
$71.83 - $95.48 $196,095 - $260,660
2,730 Added 51.19%
8,063 $742,000
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $357,311 - $450,051
5,333 New
5,333 $391,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.